日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
2023/08/14 | 20 : 00 | GlobeNewswire Inc. | Spectral MD Holdings, Ltd. (“Spectral MD” or the “Company”) ISO 13485 Certification Received for AI-Driven DeepView® Wound Imaging System | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/06/23 | 05 : 13 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/06/21 | 05 : 16 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/06/20 | 20 : 00 | Business Wire | Spectral MD Holdings, Ltd (“Spectral MD” or the “Company”) Completion of ISO 13485 Certification Audit | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/06/14 | 06 : 05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/06/13 | 20 : 00 | Business Wire | Spectral MD Holdings, Ltd (“Spectral MD” or the “Company”) Announces Publication of Peer Reviewed Proof-of-Concept Study Evaluating DeepView® Technology in Journal of Burn Care & Research | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/05/19 | 05 : 08 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/05/18 | 20 : 00 | Business Wire | Spectral MD Announces Podium Presentation at 2023 American Burn Association Annual Conference | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/05/13 | 05 : 08 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/05/13 | 05 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/05/10 | 00 : 45 | Business Wire | Wensheng Fan, CEO of Spectral MD, Discusses How Artificial Intelligence (AI) Can Revolutionize the Standard of Care in Burn Wound Diagnostics | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/05/09 | 21 : 30 | Business Wire | Wengshen Fan, CEO of Spectral MD, Discusses How Artificial Intelligence (AI) Can Revolutionize the Standard of Care in Burn Wound Diagnostics | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/19 | 05 : 55 | Business Wire | Spectral MD Holdings, Ltd. $4.0 Million Grant Award from the Medical Technology Enterprise Consortium | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/19 | 05 : 05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/17 | 22 : 23 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/17 | 22 : 22 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/11 | 22 : 07 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/11 | 20 : 15 | Business Wire | Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/04/06 | 05 : 39 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/02/15 | 06 : 28 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/02/14 | 23 : 59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/02/14 | 21 : 43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2023/02/04 | 06 : 34 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/12/23 | 07 : 23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/11/21 | 20 : 03 | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (prer14a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/11/11 | 06 : 05 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/11/09 | 20 : 19 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/08/13 | 05 : 47 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/05/14 | 05 : 31 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |
2022/03/31 | 19 : 45 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:RCLF | Rosecliff Acquisition Corporation I |